Rapid Diagnostics | Abbott Point of Care

Accidents Happen.
Head CT doesn't have to

A game-changing biomarker test that redefines the evaluation of suspected mild traumatic brain injury (mTBI).

The i-STAT TBI Plasma test is not intended for use as a point-of-care device.

Taking COVID-19 Testing to a New Level

The revolutionary NAVICA™ app helps people navigate daily life in a new normal. NAVICA displays results from the 15-minute Abbott BinaxNOW™ COVID-19 Ag Card rapid antigen test to help individuals make informed decisions.

BinaxNOW™ COVID-19 Ag Card has received U.S. Food and Drug Administration Emergency Use Authorization (EUA). Click on product information link below for more information on EUA.

Product information for professionals

Introducing ID NOW™ COVID-19 rapid POC test

The ID NOW™ COVID-19 assay is now available under U.S. Food and Drug Administration Emergency Use Authorization (EUA). High-quality molecular positive results in as little as 5 minutes, targeting COVID-19 RdRp Gene. *Emergency use only. Click on product information link below for more information on EUA.

Product Information

Point of Care Highlights

The answers you’re looking for.

Discover how our rapid diagnostics solutions help address some of the world’s greatest healthcare challenges – including yours.

Find Your Solution

Featured Products

ID NOW™

ID NOW™ is a rapid, instrument-based, isothermal system for the qualitative detection of infectious diseases.

Find out more

Cholestech LDX^™ Analyzer

The Cholestech LDX^™ Analyzer empowers healthcare professionals and patients with a lab-accurate complete lipid profile and glucose in 5 minutes per test cassette.

Find out more

Afinion™ 2

The Afinion™ 2 analyzer is a compact, rapid, multi-assay analyzer that provides valuable near patient testing at the point-of-care. With the Afinion™ System, there’s no need to send test results to the lab or spend time tracking them down.

Find out more